Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Focal cortical dysplasia IIIa (FCD IIIa) is a common histopathological finding in temporal lobe epilepsy. However, subtle alterations in the temporal neocortex of FCD IIIa renders presurgical diagnosis and definition of the resective range challenging.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To explore neuroimaging phenotyping and structural‐metabolic‐electrophysiological alterations in FCD IIIa.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Subjects</h3><p>One hundred and sixty‐seven subjects aged 4–39 years, including 64 FCD IIIa patients, 89 healthy controls and 14 FCD I patients as disease controls.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>3 T, fast‐spin‐echo T<sub>2</sub>‐weighted fluid‐attenuated inversion recovery (FLAIR), synthetic T<sub>1</sub>‐weighted magnetization prepared rapid acquisition gradient echo (MPRAGE). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Surface‐based linear model was applied to reveal neuroimaging phenotyping in FCD IIIa and assess its relationship with clinical variables. Logistic regression was implemented to identify FCD IIIa patients. Epileptogenicity mapping (EM) was conducted to explore the structural‐metabolic‐electrophysiological alterations in temporal neocortex of FCD IIIa.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Student's <i>t</i>‐test was applied to determine the significance of paired differences. Calibration curves were plotted to assess the goodness‐of‐fit (GOF) of the models, combined with the Hosmer‐Lemeshow test. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>FCD IIIa exhibited widespread hyperintensities in temporal neocortex, and these alterations correlated with disease duration (<i>P</i><sub>uncorrected</sub> < 0.01). Machine learning model accurately identified 84.4% of FCD IIIa patients, 92.1% of healthy controls and 92.9% of FCD I patients. Cross‐modality analysis showed a significant negative correlation between FLAIR hyperintensity and positron emission tomography hypometabolism <i>P</i> < 0.01). Furthermore, epileptogenic cortices were located predominantly in brain regions with FLAIR hyperintensity and hypometabolism. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>FCD IIIa exhibited widespread temporal neocortex FLAIR hyperintensity. Automated machine learning of neuroimaging patterns is conducive for accurate identification of FCD IIIa. The degree and distribution of morphological alterations related to the extent of metabolic and epileptogenic abnormalities, lending support to its potential value for reduction of the radiative and invasive approaches during presurgical workup.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>3</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>2</p></section>

Contribution of the Activated mTOR-STAT3 Pathway to the Pathogenesis of Focal Cortical Dysplasia Type IIIa in Pediatric Patients through Astrocyte Proliferation Mediation

Somatic Variants in New Candidate Genes Identified in Focal Cortical Dysplasia Type II

Mapping The Spatio-Temporal Pattern Of The Mammalian Target Of Rapamycin (Mtor) Activation In Temporal Lobe Epilepsy

Excitatory neurons and oligodendrocyte precursor cells are vulnerable to focal cortical dysplasia type IIIa as suggested by single‐nucleus multiomics

The clinico-pathological characterisation of focal cortical dysplasia type IIb genetically defined by MTOR mosaicism

Automated Detection of Focal Cortical Dysplasia Based on Magnetic Resonance Imaging and Positron Emission Tomography.

Focal cortical dysplasia II caused by brain somatic mutation of IRS-1 is associated with ERK signaling pathway activation

GABAergic Interneuron and Neurotransmission Are Mtor-Dependently Disturbed in Experimental Focal Cortical Dysplasia

Neuroimaging Phenotyping and Assessment of Structural‐Metabolic‐Electrophysiological Alterations in the Temporal Neocortex of Focal Cortical Dysplasia IIIa

Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia

Spatial omics reveals molecular changes in focal cortical dysplasia type II

Spatial transcriptomics in focal cortical dysplasia type IIb

Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB

Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II

Identification of Genetic Characteristics in Pediatric Epilepsy with Focal Cortical Dysplasia Type 2 Using Deep Whole-Exome Sequencing

Neuroimaging gradient alterations and epileptogenic prediction in focal cortical dysplasia IIIa

Identification and verification of key molecules in the epileptogenic process of focal cortical dysplasia

Aberrant adenosine signaling in patients with focal cortical dysplasia

Automated Detection of Focal Cortical Dysplasia Type II with Surface-Based Magnetic Resonance Imaging Postprocessing and Machine Learning

Increased expression of fibroblast growth factor 13 in cortical lesions of the focal cortical dysplasia

Pathophysiological mechanisms underlying the development of focal cortical dysplasia and their association with epilepsy: Experimental models as a research approach